Remarkable removal of Beta-2-microglobulin by on-line hemodiafiltration

American Journal of Nephrology

Volumn 18, Issue 2, 1998, Pages 105-108

  Lornoy, Willy ^a,b   Becaus, Ignace ^a   Billiouw, Jean Marie ^a   Sierens, Luc ^a   Van Malderen, Paul ^a  

^a OL Vrouwziekenhuis   (Belgium)

^b OL Vrouwziekenhuis   (Belgium)

Author keywords

Beta 2 microglobulin; Dialysis related amyloidosis; Hemodiafiltration; High flux hemodialysis membranes

Indexed keywords

BETA 2 MICROGLOBULIN; BICARBONATE; CREATININE; HEMODIALYSIS FLUID; NITROGEN; PHOSPHORUS; POLYSULFONE;

ADULT; AGED; ANURIA; ARTICLE; ARTIFICIAL KIDNEY; BETA 2 MICROGLOBULIN URINE LEVEL; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSATE; DIALYSIS MEMBRANE; DILUTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; UREA NITROGEN BLOOD LEVEL;

AGED; ANURIA; BETA 2-MICROGLOBULIN; BICARBONATES; BLOOD UREA NITROGEN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PHOSPHORUS; RENAL DIALYSIS; TIME FACTORS;

EID: 0031926281     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013317     Document Type: Article

References (21)

1. Vincent C, Revillard JP, Galland M, Traeger J: Serum β2-microglobulin in hemodialyzed patients. Nephron 1978;21:260-268.
2. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K: A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem Biophys Res Commun 1985;129:701-706.
3. 2-Microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1990;15: 86-88.
4. Zingraff J, Noel LM, Nardin T, Zins B, Drucke T: Beta2-microglobulin amyloidosis in chronic renal failure. N Engl J Mcd 1990;323:1070-1071.
5. Daugirdas JT, Ing TS: Handbook of Dialysis. Ed Boston, Little Brown, 1994, p 95.
6. Davison AM: Beta-2-microbglobulin and amyloidosis: Who is at risk? Nephrol Dial Transplant 1995;10(suppl 10):48-51.
7. C van Ypersele de Strihou, Jadoul M, Malghem J, Maldague B, Jamart J, and the Working Party on Dialysis Amyloidosis: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991;39: 1012-1019.
8. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F: Carpal tunnel syndrome and type of dialysis membrane. BMJ 1989;298: 867-868.
9. Bingel M, Lonnemann G, Koch KM, Shaldon S: Enhancement of in-vitro human interleukin-1 production of sodium acetate. Lancet 1987;i: 14-16.
10. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA: Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kid Int 1988;33:29-35.
11. Lornoy W, Becaus I, Billiouw JM, Sierens L, De Winter H, Van Malderen P: Beta-2-microglobuline kinetics with 6 different permeability membranes in 6 anuric hemodialysis patients. EDTA-ERA, Book of Abstract, 1987.
12. 2-Microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transplant 1987;1:223-228.
13. Zingraff J, Beyne P, Urena P, Uzan M, Nguyen Khoa Man, Descamps-Latscha B, Drueke T: Influence of haemodialysis membranes on beta-2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant 1988;3: 284-290.
14. Bommer J, Seeling P, Seeling R, Geerlings W, Bommer G, Ritz E: Determinants of plasma β2-microglobulin concentration: Possible relation to membrane biocompatibility. Nephrol Dial Transplant 1987;2:22-25.
15. Canaud B, Assounga A, Kerr P, Aznar R, Mion C: Failure of a daily haemofiltration programme using a highly permeable membrane 10 return beta-2-microglobulin concentrations to normal in haemodialysis patients. Nephrol Dial Transplant 1991;7:924-930.
16. Kerr P, Argiles A, Flavier J-L, Canaud B, Mion Charles M: Comparison of hemodialysis and hemodialfiltration: A long-term longitudinal study. Kid Int 1992;41:1035-1040.
17. Klinke B, Röckel A, Abdelhamid S, Fiegel P, Walb D: Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfonc, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs 1989;12: 697-702.
18. Lysaght MJ, Vanesh EF, Gotch F; The influence of dialysis treatment modality on the decline of remaining renal function-ASAID. Trans Am Soc Artif Internal Organs 1991;37: 598-604.
19. Canaud B, Kerr P, Argiles A, Flavier J-L, Stec F, Mion C: Is hemodiafiltration the dialysis modality of choice for the next decade? Kid Int 1993;43(suppl 4):S296-S299.
20. Koch K: Dialysis-related amyloidosis. Kid Int 1992;41:1416-1429.
21. 2-Microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Clin Nephrol 1994;42 (suppl 1):S52-S56.